Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chrzanów
Clinical trial register · Poland

Clinical Trials in Chrzanów, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 1315 Krakow 882 Poznan 705 Gdansk 657 Lodz 619
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca6 Novo Nordisk A/S3 Amgen3 Eli Lilly and Company2 Janssen Research & Development, LLC2
Site location
Warsaw1315 Krakow882 Poznan705 Gdansk657 Lodz619
All 264 locations
Target enrolment
to

Trials with a site in Chrzanów

30 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Bayer
Phase 2
360
Chrzanów, Lublin, Grodzisk Mazowiecki, Bielsko-Biala
2026-09-01
Recruiting
argenx
Phase 3
230
Krakow, Katowice, Bydgoszcz, Chrzanów, Lublin, Warsaw, Zamość
2026-06-10
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Bielsko-Biala, Chrzanów, Gdansk, Gdynia, Lodz, Tarnów
2026-05-11
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Leszno, Chrzanów, Tarnów, Lublin, Płock, Gdynia, Ustroń, Szczecin
2026-05-11
Recruiting
Poland-Italy Aortic Research Bridge Real World Registry
NCT07476196Abdominal Aortic Aneurysm
American Heart of Poland
Observational
200
Bialystok, Bielsko-Biala, Bytom, Chrzanów, Ełk, Gdynia, Kielce, Krakow
2026-03-01
Recruiting
Acesion Pharma
Phase 2
200
Bydgoszcz, Chrzanów, Dąbrowa Górnicza, Katowice, Szczecin, Tychy
2025-10-22
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Bialystok, Bydgoszcz, Chojnice, Chorzów, Chrzanów, Częstochowa, Dębica, Gdansk
2025-09-06
Recruiting
American Heart of Poland
Not applicable
1,000
Chrzanów, Bielsko-Biala, Dąbrowa Górnicza, Ustroń, Katowice, Kędzierzyn-Koźle, Opole, Tychy
2025-08-25
Recruiting
Amgen
Phase 3
12,800
Bialystok, Bielsko-Biala, Bydgoszcz, Chojnice, Chrzanów, Dębica, Gdynia, Katowice
2025-07-25
Not yet open
Zhejiang Zylox Medical Device Co., Ltd.
Not applicable
153
Chrzanów
2025-06-30
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Bialystok, Bydgoszcz, Chrzanów, Elblag, Gdansk, Gdynia, Giżycko, Katowice
2025-06-25
Recruiting
MDCECRO LLC
Not applicable
153
Chrzanów
2025-06-02
Recruiting
AstraZeneca
Phase 3
990
Bialystok, Bydgoszcz, Chrzanów, Karczew, Katowice, Kielce, Krakow, Lodz
2025-03-18
Recruiting
AstraZeneca
Phase 3
11,300
Bialystok, Biała Podlaska, Bydgoszcz, Chojnice, Chrzanów, Częstochowa, Gdansk, Gdynia
2025-03-14
Recruiting
STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions
NCT06734221Popliteal Artery Stenosis Above the Knee, Peripheral Artery Disease, Superficial Femoral Artery Stenosis
Balton Sp.zo.o.
Not applicable
120
Chrzanów, Szczecin
2024-09-15
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Ostrów Wielkopolski, Chrzanów, Wroclaw, Puławy, Rzeszów, Gdynia, Dąbrowa Górnicza, Gliwice
2024-06-25
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bialystok, Bielsko-Biala, Bydgoszcz, Chorzów, Chrzanów, Elblag, Gdansk, Krakow
2024-04-30
Recruiting
AstraZeneca
Phase 3
3,850
Biała Podlaska, Bielsko-Biala, Bydgoszcz, Chrzanów, Gdansk, Gdynia, Katowice, Kazimierza Wielka
2024-04-12
Active, closed
AstraZeneca
Phase 3
2,554
Chrzanów, Gdynia, Krakow, Lodz, Lublin, Olsztyn, Poznan, Rzeszów
2024-03-29
Active, closed
Eli Lilly and Company
Phase 3
17,300
Bialystok, Bydgoszcz, Chrzanów, Dąbrowa Górnicza, Elblag, Gdansk, Grudziądz, Katowice
2024-03-05
Active, closed
AstraZeneca
Phase 3
1,835
Chrzanów, Krakow, Lodz, Poznan, Radom, Rzeszów, Szczecin, Warsaw
2023-11-07
Active, closed
AskBio Inc
Phase 2
150
Chrzanów, Lublin
2023-10-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Poznan, Bydgoszcz, Torun, Chrzanów, Krakow, Tarnów, Legnica, Lublin
2023-10-09
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Biała Podlaska, Bydgoszcz, Chojnice, Chorzów, Chrzanów, Elblag, Gdansk, Gdynia
2023-04-11
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Ruda Śląska, Dąbrówka, Bygdoszcz, Chrzanów, Krakow, Wroclaw, Lublin, Poniatowa
2023-03-01
Active, closed
Amgen
Phase 3
7,297
Bełchatów, Bielsko-Biala, Chrzanów, Dąbrowa Górnicza, Dębica, Gdansk, Giżycko, Kędzierzyn-Koźle
2022-12-14
Recruiting
AstraZeneca
Phase 3
3,527
Chrzanów, Lodz, Rzeszów, Warsaw, Wroclaw, Łańcut, Łęczna
2022-12-13
Recruiting
Wroclaw Medical University
Phase 4
1,000
Bydgoszcz, Grudziądz, Torun, Chrzanów, Gorlice, Krakow, Nowy Targ, Oświęcim
2022-09-22
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Bialystok, Bydgoszcz, Chojnice, Chrzanów, Knurów, Krakow, Lodz, Lublin
2022-01-19
Active, closed
Anthos Therapeutics, Inc.
Phase 2
1,287
Gdynia, Chrzanów, Krakow, Wroclaw, Żarów, Lublin, Zamość, Płock
2021-02-02
Rows per page Showing 1–30 of 30
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/chrzan-w

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 30 of those studies with a site in Chrzanów.

How many clinical trials are recruiting in Chrzanów?

16 of the 30 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chrzanów), 30 studies
PhaseStudiesRecruitingShare
Phase 320966.7%
Not applicable4313.3%
Phase 24213.3%
Observational113.3%
Phase 4113.3%

Most active sponsors

Lead sponsors with the most studies (Chrzanów)
Lead sponsorStudiesRecruiting
AstraZeneca64
Amgen32
Novo Nordisk A/S31
American Heart of Poland22
Eli Lilly and Company20
Janssen Research & Development, LLC20
Acesion Pharma11
Alnylam Pharmaceuticals11
Anthos Therapeutics, Inc.10
argenx11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.